Thalomid thalidomide: Phase II data; marketed to treat erythema nodosum leprosum in leprosy

Researchers presented additional data from a previously reported Phase II study showing a ?25 percent reduction

Read the full 167 word article

How to gain access

Continue reading with a
two-week free trial.